MedTrace Logo

Development and Validation of a Language Screening Test in Acute Right Hemispheric Strokes

NCT03622606 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2024-08-21

No results posted yet for this study

Summary

This is a bi-centric study whose main objective is the validation of a rapid screening test for language disorders in the acute phase of right hemisphere stroke.

Primary objective

The main objective is the validation of a rapid language disorder screening tool that will be used in the acute phase of right hemispheric stroke.

Secondary objectives

Secondary objectives are:

* Characterize the "atypical crossed aphasia" since the acute phase of stroke with a large cohort of patients , which, to our knowledge, has never been done.
* Re-evaluate the number of patients with acute language disorder in right hemisphere stroke.
* Validate the use of R-LAST by different categories of carers

Conditions

Interventions

DIAGNOSTIC_TEST

Right Language screening test (R-LAST)

Validation of the Right Language screening test in acute and subacute phase of right stroke

Sponsors & Collaborators

  • Centre Hospitalier Sud Francilien

    collaborator OTHER

  • Versailles Hospital

    lead OTHER

Principal Investigators

  • Didier SMADJA, Neurologist · Sud Francilien Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-25
Primary Completion
2023-06-08
Completion
2024-10-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03622606 on ClinicalTrials.gov